Denying access to long-acting injectable treatment for HIV: an open letter
- PMID: 39632049
- DOI: 10.1016/S2352-3018(24)00305-9
Denying access to long-acting injectable treatment for HIV: an open letter
Conflict of interest statement
SK has had grants paid to his institution from Merck, ViiV Healthcare, and Gilead; and honoraria from Pfizer in the past 36 months. CO has a grant from Horizon Europe paid to her institution for this work. All other authors declare no competing interests.
Publication types
LinkOut - more resources
Full Text Sources